Vaccines Personalized: How Genetics Will Shape Your Immunity
"Unlocking the code to individual immune responses for better protection in the age of personalized medicine."
Vaccines stand as one of medicine's greatest achievements, effectively preventing and controlling infectious diseases. Historically, vaccines have been administered with the goal of inducing a protective immune response in everyone. However, the reality is that individuals respond differently to vaccines; what works well for one person may not be as effective for another.
For over a century, vaccines have dramatically reduced the incidence and mortality of diseases like polio, smallpox, and measles. But the field is constantly evolving, seeking to address new and old challenges. The development of vaccines has been categorized into generations: the first involving live attenuated or inactivated pathogens, and the second utilizing isolated cellular components. Advances in DNA technology and carbohydrate chemistry have propelled the second generation forward.
Traditional vaccine development faces hurdles such as non-cultivable pathogens and those with highly variable antigens. The ultimate aim of vaccination is to trigger a robust immune response in everyone, yet achieving universal protection is rare. Factors like gender, age, co-existing conditions, and genetics influence how individuals respond to vaccines. Specifically, an individual's genetic makeup shapes both innate and adaptive immune responses, impacting vaccine effectiveness against viruses like smallpox and influenza.
From Standard Vaccines to Personalization
Vaccines are a cornerstone of public health and prevent millions of deaths annually, but traditional approaches have inherent limitations in addressing individual differences in immune responses and disease susceptibility. Personalized vaccine development analyzes an individual's genetic data, immune response, and other biomarkers. Vaccinomics, immunogenetics, systems biology, and microbiome research examine the causes of inter-individual variation so vaccines can be tailored to individuals and communities. Recent work also emphasizes that metabolic and genetic differences can affect vaccine efficacy across populations.
Decoding Your Immunity: How Genetics Influence Vaccine Response
The burgeoning field of genomics has opened new avenues for vaccine research. With the first draft of a living organism's genome sequence completed in the mid-90s, scientists gained a fresh perspective. Today, the complete genomic information of numerous microorganisms, including those causing human diseases, is available. High-throughput sequencing technologies are driving sophisticated approaches to understand vaccine-induced immune responses, heralding an era of personalized and predictive vaccinology.
- Vaccinomics: Studies how genes affect the body's response to vaccines.
- Immunogenetics: Focuses on genes related to the immune system.
- Immunogenomics: Examines the genomic basis of immunity.
- Metagenomics: Studies the genetic material from microbial communities.
Genomics and New Vaccine Platforms
A population-based study examined 357,806 vaccinated participants with high-resolution HLA genotyping data, including a subset of 175,000 participants with antibody serology results. Recent reviews of personalized cancer vaccines describe DNA-, mRNA-, peptide-, dendritic-cell-, and whole-cell-based platforms, while also examining their immunological challenges. Broader personalized-vaccine research integrates genomics, transcriptomics, proteomics, and immunology to pursue greater efficacy and safety.
Genes and Vaccine Response
A systematic review and meta-analysis examined 13 studies involving 11,686 subjects and evaluated associations between HLA and other immune-gene variations and responses to MMR-II, HepB, influenza, and MenC vaccines. Research on measles-mumps-rubella vaccination reported that polymorphisms in immune-response genes, together with HLA alleles, explained approximately 30% of inter-individual variability in humoral response. Systems vaccinology complements these gene-association studies by analyzing immune responses to vaccination through a systems-based approach.
The Future of Vaccines: Personalized and Predictive
The immune response network theory posits that a vaccine's effect is the cumulative result of interactions driven by a host of genes and their interplay, making it theoretically predictable. Scientists are increasingly recognizing the impact of epigenetics and metagenomics on vaccine responses. Overcoming obstacles such as genetic variability and pathogen evolution requires a systemic approach. By integrating various layers of omic information, researchers aim to identify biomarker signatures that reveal how innate and adaptive responses can be integrated into a unified network. To realize the full potential of personalized and predictive vaccinology, ongoing research is essential to navigate the complex interplay between genetics, immunity, and environmental factors, ultimately leading to more effective and safer vaccines.
Personalized Cancer Vaccines in Practice
A real-world report described the clinical course of patients with glioblastoma treated with a personalized neoantigen-derived peptide vaccine as part of an individual healing attempt. Reviews describe personalized cancer vaccines as using the unique genetic and molecular profile of a person's tumor to elicit targeted immune responses. The approaches discussed include peptide, mRNA, DNA, and autologous dendritic-cell vaccines, underscoring the individualized nature of this emerging field.